[Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study].
作者信息
Tissot R, Bartholini G, Constantinidis J, Eisenring J J, Geissbühler F, Yanniotis G, de Ajuriaguerra J
出版信息
Schweiz Med Wochenschr. 1973 Oct 20;103(42):1466-74.
PMID:4750149
Abstract
摘要
相似文献
1
2
3
[Treatment of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor].左旋多巴与脱羧酶抑制剂治疗帕金森综合征
Arch Invest Med (Mex). 1974;5(2):105-16.
4
5
[Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].[联合用药（左旋多巴加脱羧酶抑制剂（Ro 8-0576））治疗帕金森病的经验]
Wien Med Wochenschr. 1973 Jun 30;123(26):433-5.
6
[CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].[CB 154治疗帕金森病。与左旋多巴和脱羧酶抑制剂联合使用的结果]
Acta Neurol (Napoli). 1976 Jul-Aug;31(4):479-48.
7
[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].左旋多巴与脱羧酶抑制剂（苄丝肼，Ro 4-4602）联合治疗帕金森病的2年经验
Wien Med Wochenschr. 1974 Jun 1;124(22):340-4.
8
9
[Therapeutic association of L-dopa and an inhibitor of peripheral decarboxylase in Parkinsonism. Preliminary results].
Acta Neurol (Napoli). 1973 Mar-Apr;28(2):208-12.
10
[Treatment of parkinsonism with L-dopa and an L-aromatic amino acid inhibitor].
Harefuah. 1972 Nov 1;83(9):362-4.
引用本文的文献
1
Study of deterioration in long-term treatment of parkinsonism with L-dopa plus decarboxylase inhibitor.左旋多巴加脱羧酶抑制剂长期治疗帕金森病的疗效减退研究。
J Neural Transm. 1976;38(3-4):249-58. doi: 10.1007/BF01249442.
Zotero 插件